OptiNose, Inc. (OPTN): Price and Financial Metrics
OPTN Price/Volume Stats
Current price | $0.65 | 52-week high | $2.10 |
Prev. close | $0.68 | 52-week low | $0.65 |
Day low | $0.65 | Volume | 302,700 |
Day high | $0.70 | Avg. volume | 761,545 |
50-day MA | $0.87 | Dividend yield | N/A |
200-day MA | $1.17 | Market Cap | 73.48M |
OPTN Stock Price Chart Interactive Chart >
OptiNose, Inc. (OPTN) Company Bio
OptiNose, Inc. focuses on the development and commercialization of products for patients treated by ear, nose, and throat; and allergy specialists in the United States. The company's lead product includes XHANCE, a therapeutic product utilizing its proprietary breath powered exhalation delivery system that delivers a topically-acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps. It also markets AVP-825 for the acute treatment of migraines in adults through its license agreement with Avanir Pharmaceuticals, Inc. In addition, the company is developing XHANCE for the treatment of chronic sinusitis; OPN-300 for the treatment of Prader-Willi syndrome, a rare genetic obesity disorder, as well as autism spectrum disorder; and OPN-021 for the treatment of narcolepsy or Parkinson diseases. Further, it is involved in developing antibiotics, anticholinergics, antihistamines, mucolytics, leukotriene inhibitors, and other medication classes. The company was founded in 2010 and is based in Yardley, Pennsylvania.
OPTN Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Continue Researching OPTN
Here are a few links from around the web to help you further your research on OptiNose Inc's stock as an investment opportunity:OptiNose Inc (OPTN) Stock Price | Nasdaq
OptiNose Inc (OPTN) Stock Quote, History and News - Yahoo Finance
OptiNose Inc (OPTN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...